ADAMTS-9 acts as a functional tumor suppressor in gastric cancer through inhibiting the oncogenic AKT/mammalian target of rapamycin (mTOR) signaling pathway and ADAMTS-9 is related to beta cell function in type 2 diabetes [118]. This evidence concerns the gene ADAMTS9 and type 2 diabetes mellitus.